Gene: APOC3
Official Full Name: apolipoprotein C3provided by HGNC
Gene Summary: This gene encodes a protein component of triglyceride (TG)-rich lipoproteins (TRLs) including very low density lipoproteins (VLDL), high density lipoproteins (HDL) and chylomicrons. The encoded protein plays a role in role in the metabolism of these TRLs through multiple modes. This protein has been shown to promote the secretion of VLDL1, inhibit lipoprotein lipase enzyme activity, and delay catabolism of TRL remnants. Mutations in this gene are associated with low plasma triglyceride levels and reduced risk of ischemic cardiovascular disease, and hyperalphalipoproteinemia, which is characterized by elevated levels of high density lipoprotein (HDL) and HDL cholesterol in human patients. This gene and other related genes comprise an apolipoprotein gene cluster on chromosome 11. [provided by RefSeq, Sep 2017]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA17023 | APOC3 Knockout cell line (AC16) | Human | APOC3 | 1:3-1:4 | negative | Online Inquiry |
| KOA32471 | APOC3 Knockout cell line (BEAS-2B) | Human | APOC3 | 1:3~1:4 | negative | Online Inquiry |
| KOA47881 | APOC3 Knockout cell line (U-2932) | Human | APOC3 | 1:2-1:4 | negative | Online Inquiry |
| KOA63281 | APOC3 Knockout cell line (TPC-1) | Human | APOC3 | 1:5-1:8 | negative | Online Inquiry |
| KOA78710 | APOC3 Knockout cell line (NCM460) | Human | APOC3 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.